πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

Vertex Pharmaceuticals (Australia) Patents

Full USPTO pharma patent portfolio for Vertex Pharmaceuticals (Australia) β€” grant dates, expiration, and drug cross-links.

Patents
991
Expiring ≀24m
63

Quick answer

Vertex Pharmaceuticals (Australia) has 991 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 63 expire within 24 months β€” use filters for patent-cliff planning.

Page 17 of 21

  1. US 7553855

    Compositions of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7547794

    Compositions useful as inhibitors of protein kinases

    Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7531523

    Sodium channel protein type III alpha-subunit splice variant

    Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7531570

    Treatment of diseases using ICE inhibitors

    Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7531536

    Pyrazole compounds useful as protein kinase inhibitors

    Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7531556

    Compositions useful as inhibitors of rock and other protein kinases

    Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7527952

    Crystals of inosine monophosphate dehydrogenase/oxidized inosine monophosphate thiomidate intermediate/mycophenolic acid (IIMPDH/XMP*/MPA)

    Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7528142

    Aminopyrimidines useful as kinase inhibitors

    Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7528138

    Pyrazolo[1,5-a]pyrimidines useful as inhibitors of protein kinases

    Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7517987

    Caspase inhibitors and uses thereof

    Expires Mon Apr 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7514448

    Azaindoles useful as inhibitors of rock and other protein kinases

    Expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7507826

    Azaindoles useful as inhibitors of JAK and other protein kinases

    Expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7504515

    Polymorphic forms of (S)-1-cyanobutan-2-yl (S)-1-(3-(3-(3-methoxy-4- (oxazol-5-yl)phenyl) ureido)phenyl) ethylcarbamate

    Expires Mon Mar 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7501415

    Selective inhibitors of ERK protein kinase and uses thereof

    Expires Mon Mar 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7494660

    HCV NS3-NS4A protease resistance mutants

    Expires Mon Feb 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7495103

    Modulators of ATP-binding cassette transporters

    Expires Mon Feb 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7495014

    Gyrase inhibitors and uses thereof

    Expires Mon Feb 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7494988

    Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease

    Expires Mon Feb 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7491730

    Compositions useful as inhibitors of GSK-3

    Expires Mon Feb 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7488727

    Thiazole compounds useful as inhibitors of protein kinase

    Expires Mon Feb 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7485664

    Inhibitors of TACE

    Expires Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7465738

    Compounds useful as promoters of SMN2

    Expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7462612

    Pyridine inhibitors of ERK2 and uses thereof

    Expires Mon Dec 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7456190

    Compositions useful as protein kinase inhibitors

    Expires Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7452873

    Inhibitors of GSK-3 and uses thereof

    Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7446112

    Modulators of muscarinic receptors

    Expires Mon Oct 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7446199

    Compositions useful as inhibitors of protein kinases

    Expires Mon Oct 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7442718

    Inhibitors of aspartyl protease

    Expires Mon Oct 23 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7442790

    Caspase inhibitors and uses thereof

    Expires Mon Oct 23 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7439249

    Inhibitors of phosphatases

    Expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7432290

    Inhibitors of IMPDH enzyme

    Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7432292

    Sulfhydantoins as phosphate isosteres

    Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7427681

    Pyrazole compounds useful as protein kinase inhibitors

    Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7423049

    Inhibitors of p38

    Expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7419967

    Sulfonamide inhibitors of aspartyl protease

    Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7417029

    Prodrug of an ice inhibitor

    Expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7414046

    Gyrase inhibitors and uses thereof

    Expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7410956

    Caspase inhibitor prodrugs

    Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7407976

    Thiazoles and oxazoles useful as modulators of ATP-Binding Cassette transporters

    Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7407964

    Caspase inhibitors and uses thereof

    Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7407962

    Heteroaryl compounds useful as inhibitors or protein kinases

    Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7390815

    Pyrazole compounds useful as protein kinase inhibitors

    Expires Mon Jun 19 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7390808

    Inhibitors of GSK-3 and crystal structures of GSK-3Ξ² protein and protein complexes

    Expires Mon Jun 19 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7388017

    Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease

    Expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7381827

    Processes and intermediates

    Expires Mon May 29 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7378422

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7371372

    Compositions comprising IMPDH inhibitors and uses thereof for treating HCV infection

    Expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7365092

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Expires Mon Apr 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Vertex Pharmaceuticals (Australia) have?

991 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Vertex Pharmaceuticals (Australia) patents expire?

63 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.